Bharat Biotech's Covaxin gets restricted emergency nodOut of the total vaccination, Covaxin has so far been given to 19 lakh people, Paul said. Paul said the vaccine has stood the test of time ...
12 Mar, 2021, 08.32 AM IST
DGCI's Subject Expert Committee recommends waiving off 'clinical trial mode' from CovaxinAfter more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinic...
11 Mar, 2021, 03.04 PM IST
Bharat Bio seeks review of clinical trial mode for Covaxin VaccineThe drug regulator’s subject expert committee (SEC) will meet on Thursday to consider the vaccine maker’s request and review the data. “The...
10 Mar, 2021, 09.45 AM IST
Bharat Biotech approaches DCGI, seeks Covaxin's removal from 'clinical trial mode'The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...
09 Mar, 2021, 05.52 PM IST
Covaxin efficacy data has no effect on opposition statesA day after Hyderabad-based Bharat Biotech reported its interim data, the three states on Thursday said they would wait for a formal approv...
05 Mar, 2021, 08.01 AM IST
Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drugThe company on Monday said the clinical trial was initiated in November at BJ Government Medical College and Sassoon General Hospital in Pu...
22 Feb, 2021, 05.01 PM IST
13,000 volunteers administered 2nd dose of Covaxin in phase-3 trials: Bharat BiotechCovaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...
22 Jan, 2021, 04.56 PM IST
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 cl...
20 Jan, 2021, 11.49 AM IST
Bharat Biotech to pay compensation if Covaxin causes side effects16 Jan, 2021, 05.44 PM IST
Bharat Biotech to pay compensation if Covaxin causes side effects"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vacci...
16 Jan, 2021, 04.43 PM IST
Healthcare NGO raises concerns over CovaxinA day before India begins the world’s largest Covid-19 vaccination drive, a group of healthcare-focused NGOs has sought clarifications from...
16 Jan, 2021, 01.15 PM IST
Medical experts back both Serum Institute and Bharat Biotech's vaccines in IndiaThe endorsement letter from 49 medical experts, led by AIIMS’ former director TD Dogra, comes after reports emerged that some healthcare wo...
16 Jan, 2021, 01.13 PM IST
How SEC changed Covaxin stanceAt the Jan 2 meeting, the firm presented more data and notably “requested for consideration of their proposal in the wake of incidence of n...
06 Jan, 2021, 10.25 AM IST
During pandemic, vaccine’s restricted use considered based on safety, immunogenicity data: ICMR chiefDrugs Controller General of India (DCGI) had on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, an...
05 Jan, 2021, 09.15 PM IST
Bharat Biotech recruits 23,000 volunteers for Phase III trials of its coronavirus vaccineThe Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the countrys first an...
03 Jan, 2021, 12.50 PM IST
DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situationThe subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.
03 Jan, 2021, 11.58 AM IST
- Clinical trials for new ayurvedic formulations find few takers
The proposals for clinical trials of new ayurvedic formulations have come under scrutiny with a major chunk of ayurvedic companies particul...
18 Feb, 2009, 07.01 PM IST